Felbamate(Felbamate Tablets, USP (400 mg and 600 mg))

Amneal Pharmaceuticals of New York LLC🇺🇸 United States

FDA Page

Effective Date: Dec 31, 2023
Approval ID: 1aa40de5-c02d-49d6-8722-ed88c40c3ba6
Products: 2 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Felbamate Tablets, USP (400 mg and 600 mg)

Quick Stats

Total Products2

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.